STOCK TITAN

Ametek, Inc. - AME STOCK NEWS

Welcome to our dedicated page for Ametek news (Ticker: AME), a resource for investors and traders seeking the latest updates and insights on Ametek stock.

AMETEK, Inc. (NYSE: AME) is a leading global provider of industrial technology solutions, with annual sales of over $6 billion. The company operates through two primary segments: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG). EIG designs and manufactures advanced instruments for the process, aerospace, power, and industrial markets. EMG focuses on highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects.

With a workforce of approximately 15,000 employees, AMETEK has a strong presence worldwide, operating over 120 manufacturing locations and maintaining 100 sales and service locations in more than 30 countries. The company is committed to four key growth strategies: Operational Excellence, Strategic Acquisitions & Alliances, Global & Market Expansion, and New Product Development. Through these strategies, AMETEK aims to double its size and profitability within the next five years.

Recent achievements include the acquisition of Paragon Medical for approximately $1.9 billion, further enhancing AMETEK's capabilities in the medical technology sector. The company also declared a regular quarterly dividend of $0.28 per share, reflecting its strong financial performance and commitment to delivering shareholder value.

Founded in 1930 and listed on the NYSE for over 90 years, AMETEK is a component of the S&P 500. The company's disciplined focus on cash generation and capital deployment supports its long-term objective of achieving double-digit percentage growth in earnings per share and superior returns on total capital. For more information, visit www.ametek.com.

Rhea-AI Summary

AMETEK has appointed Suzanne Stefany to its Board of Directors, bringing extensive experience in finance and governance. A Partner at PJT Partners, Stefany has a strong background in capital markets and has previously held leadership positions at notable firms. Her appointment is expected to enhance AMETEK's growth strategies and align with its commitment to sustainability. AMETEK reported $5.5 billion in sales for 2021 and aims for double-digit earnings growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
management
-
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) reported record financial results for Q2 2022, with sales reaching $1.51 billion, a 9% increase year-over-year, driven by 12% organic sales growth. Operating income also hit a record $364.8 million, representing a 15% rise. Earnings per diluted share on a GAAP basis were $1.22, while adjusted earnings were a record $1.38, up 20% from Q2 2021. The company raised its full-year earnings guidance to $5.46 to $5.54 per diluted share, indicating strong demand and operational performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
-
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) will release its second quarter 2022 earnings before market opens on Tuesday, August 2, 2022. An investor conference call will follow at 8:30 AM ET the same day, available via webcast on their website. AMETEK reported $5.5 billion in sales for 2021, focusing on double-digit EPS growth and superior capital returns. The company employs strategies like operational excellence, new product development, global expansion, and strategic acquisitions to drive sustainable growth. The stock is part of the S&P 500.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) has finalized an amended and restated Revolving Credit Facility, increasing its size from $1.5 billion to $2.3 billion. The facility, now maturing in May 2027, was originally set to expire in October 2023. Alongside this expansion, AMETEK has terminated an $800 million delayed draw, bank term loan. This enhanced credit facility aims to support the company's growth strategies, including potential strategic acquisitions, as stated by CFO William J. Burke.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
none
-
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) announced the appointment of Mikael Näsström as Vice President of Commercial Excellence on May 9, 2022. In this newly created role, Näsström will lead commercial initiatives to drive sales growth and enhance global marketing efforts. His experience spans various leadership positions within AMETEK since 2014 and previous roles at Danaher Corporation. AMETEK reported sales of $5.5 billion in 2021, focusing on strategies for operational excellence, new product development, market expansion, and strategic acquisitions to target double-digit earnings growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
none
-
News
Rhea-AI Summary

AMETEK has declared a quarterly dividend of $0.22 per share for Q2 2022, payable on June 30, 2022, to shareholders on record as of June 10, 2022. The company, a leading global manufacturer, achieved $5.5 billion in sales for 2021. AMETEK aims for double-digit growth in earnings per share and focuses on cash generation and capital deployment. The company is part of the S&P 500, reflecting its strong market position and growth strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.79%
Tags
dividends
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) announced on May 6, 2022, a significant $1 billion share repurchase authorization, replacing the $500 million prior approval with around $313 million remaining. This move aims to enhance shareholder value through strategic stock repurchases while maintaining a focus on strategic acquisitions using strong cash flow. With 2021 sales of $5.5 billion, AMETEK continues to prioritize double-digit percentage growth in earnings per share and superior returns on total capital.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.79%
Tags
buyback
-
News
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) reported strong financial results for Q1 2022, with sales reaching $1.46 billion, a 20% increase year-over-year. Operating income surged 20% to $353.2 million, yielding a 24.2% operating margin. Adjusted earnings per diluted share rose 24% to $1.33. The Electronic Instruments Group (EIG) led sales growth at $987.8 million, up 25%, while the Electromechanical Group (EMG) saw 11% growth. The company anticipates high-single digit sales growth for 2022 and adjusted EPS of $5.34 to $5.44.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.59%
Tags
none
-
Rhea-AI Summary

AMETEK, a leading manufacturer of electronic instruments and electromechanical devices, will release its first-quarter 2022 earnings before the market opens on May 3, 2022. The company will also host a webcast of its investor conference call at 8:30 AM ET on the same day. In 2021, AMETEK achieved $5.5 billion in sales and aims for double-digit percentage growth in earnings per share over the business cycle. The company is a component of the S&P 500, focusing on operational excellence and strategic acquisitions to drive growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) has appointed Sheraz Ahmed as Vice President and General Manager of its Maintenance, Repair, and Overhaul (MRO) division, effective April 1, 2022. He succeeds Brian Hoffmann, who is retiring after 17 years. Ahmed, who joined AMETEK in 2015, brings extensive experience from UTC Aerospace Systems and Goodrich. This leadership transition is expected to enhance the MRO division's growth and success. In 2021, AMETEK reported sales of $5.5 billion and aims for double-digit growth in earnings per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
management

FAQ

What is the current stock price of Ametek (AME)?

The current stock price of Ametek (AME) is $183.36 as of December 20, 2024.

What is the market cap of Ametek (AME)?

The market cap of Ametek (AME) is approximately 42.0B.

What does AMETEK, Inc. do?

AMETEK, Inc. is a global provider of industrial technology solutions, focusing on advanced instruments and engineered automation solutions for various markets.

What are the key business segments of AMETEK?

AMETEK operates through two main segments: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG).

How many employees does AMETEK have?

AMETEK has approximately 15,000 employees worldwide.

What are AMETEK's growth strategies?

AMETEK's growth strategies include Operational Excellence, Strategic Acquisitions & Alliances, Global & Market Expansion, and New Product Development.

What recent acquisitions has AMETEK made?

Recently, AMETEK acquired Paragon Medical for approximately $1.9 billion, enhancing its capabilities in the medical technology sector.

What is AMETEK's annual sales figure?

AMETEK's annual sales exceed $6 billion.

When was AMETEK founded?

AMETEK was founded in 1930.

Is AMETEK listed on any stock exchange?

Yes, AMETEK is listed on the New York Stock Exchange (NYSE) under the symbol AME.

What is AMETEK's dividend policy?

AMETEK declared a regular quarterly dividend of $0.28 per share, reflecting its strong financial performance.

Where can I find more information about AMETEK?

For more information, visit AMETEK's official website at www.ametek.com.

Ametek, Inc.

NYSE:AME

AME Rankings

AME Stock Data

41.96B
230.21M
0.41%
88.2%
1.15%
Specialty Industrial Machinery
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
BERWYN